Home/Filings/4/0001879231-24-000004
4//SEC Filing

Buck Kristen K 4

Accession 0001879231-24-000004

CIK 0000320017other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 5:21 PM ET

Size

6.8 KB

Accession

0001879231-24-000004

Insider Transaction Report

Form 4
Period: 2024-10-01
Buck Kristen K
EVP, R&D and CMO
Transactions
  • Award

    Common Stock

    2024-10-01$2.93/sh+15,000$43,95069,035 total
  • Tax Payment

    Common Stock

    2024-10-01$2.93/sh6,363$18,64462,672 total
Footnotes (3)
  • [F1]Reflects 15,000 in performance-based stock units, the criteria for which was satisfied on October 1, 2024, and which vested in full on that same day.
  • [F2]Includes 30,325 unvested restricted stock.
  • [F3]Shares withheld as payment of a tax liability on vesting of performance-based stock units.

Issuer

LISATA THERAPEUTICS, INC.

CIK 0000320017

Entity typeother

Related Parties

1
  • filerCIK 0001879231

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 5:21 PM ET
Size
6.8 KB